UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases

Science (American Association for the Advancement of Science), 2020-10, Vol.370 (6512), p.66-69

2020

Volltextzugriff (PDF)

KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (31), p.9596-9601

2015

Volltextzugriff (PDF)

N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation

PloS one, 2014-07, Vol.9 (7), p.e103727-e103727

2014

Volltextzugriff (PDF)

Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons

Neurobiology of disease, 2018-03, Vol.111, p.26-35

2018

Volltextzugriff (PDF)

Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1948, p.45

2019

Volltextzugriff (PDF)

A traffic jam leads to Lewy bodies

Nature neuroscience, 2019-07, Vol.22 (7), p.1043

Bartels, Tim

2019

Volltextzugriff (PDF)

pTSara-NatB, an improved N-terminal acetylation system for recombinant protein expression in E. coli

PloS one, 2018-07, Vol.13 (7), p.e0198715-e0198715

2018

Volltextzugriff (PDF)

Probing Structural Changes in Alpha-Synuclein by Nuclear Magnetic Resonance Spectroscopy

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1948, p.157

2019

Volltextzugriff (PDF)

Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

EMBO molecular medicine, 2024-07, Vol.16 (7), p.1657-1674

2024

Volltextzugriff (PDF)

Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking

Frontiers in neuroscience, 2021-02, Vol.15, p.639414

2021

Volltextzugriff (PDF)

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity

NPJ Parkinson's Disease, 2023-01, Vol.9 (1), p.4-15, Article 4

2023

Volltextzugriff (PDF)

Conformation-Specific Detection of α-Synuclein: The Search for a Biomarker in Parkinson Disease

JAMA neurology, 2017-02, Vol.74 (2), p.146

Bartels, Tim

2017

Volltextzugriff (PDF)

Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1948, p.69

2019

Volltextzugriff (PDF)

New insights into cellular α-synuclein homeostasis in health and disease

Current opinion in neurobiology, 2016-02, Vol.36, p.15-22

2016

Volltextzugriff (PDF)

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

Nature (London), 2011-09, Vol.477 (7362), p.107-110

2011

Volltextzugriff (PDF)

ExPLAining early synucleinopathies

Brain (London, England : 1878), 2015-06, Vol.138 (Pt 6), p.1449-1451

2015

Volltextzugriff (PDF)

ExPLAining early synucleinopathies: Figure 1

Brain (London, England : 1878), 2015-06, Vol.138 (6), p.1449-1451

2015

Volltextzugriff (PDF)

In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells

The Journal of biological chemistry, 2013-03, Vol.288 (9), p.6371-6385

2013

Volltextzugriff (PDF)

Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction

The Journal of biological chemistry, 2014-08, Vol.289 (31), p.21490-21507

2014

Volltextzugriff (PDF)

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

Science (American Association for the Advancement of Science), 2017-09, Vol.357 (6354), p.891-898

2017

Volltextzugriff (PDF)

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1

The EMBO journal, 2010-10, Vol.29 (20), p.3571-3589

2010

Volltextzugriff (PDF)

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Nature communications, 2015-06, Vol.6 (1), p.7314, Article 7314

2015

Volltextzugriff (PDF)

The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix Folding

Biophysical journal, 2010-10, Vol.99 (7), p.2116-2124

2010

Volltextzugriff (PDF)

Refolding of helical soluble α‐synuclein through transient interaction with lipid interfaces

FEBS letters, 2018-05, Vol.592 (9), p.1464-1472

2018

Volltextzugriff (PDF)

Purification of α‑Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity

Biochemistry (Easton), 2015-01, Vol.54 (2), p.279-292

2015

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(196)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(207)
Japanisch
(17)
Deutsch
(6)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases

KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity

N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation

Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons

Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils

A traffic jam leads to Lewy bodies

pTSara-NatB, an improved N-terminal acetylation system for recombinant protein expression in E. coli

Probing Structural Changes in Alpha-Synuclein by Nuclear Magnetic Resonance Spectroscopy

Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity

Conformation-Specific Detection of α-Synuclein: The Search for a Biomarker in Parkinson Disease

Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers

New insights into cellular α-synuclein homeostasis in health and disease

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

ExPLAining early synucleinopathies

ExPLAining early synucleinopathies: Figure 1

In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells

Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix Folding

Refolding of helical soluble α‐synuclein through transient interaction with lipid interfaces

Purification of α‑Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity

Suchergebnisse filtern